| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Mrz―12 |
Changes in self-measured blood pressure monitoring use in 14 states from 2019 to 2021 - Impact of the COVID-19 pandemic |
Jing Fang, Wen Zhou, Donald K Hayes, Hilary K Wall, Gregory Wozniak, Alina Chung, Fleetwood Loustalot |
| 2 |
[GO] |
2023―Sep―29 |
Rural and Urban Differences in Hypertension Management Through Telehealth Before and During the COVID-19 Pandemic Among Commercially Insured Patients |
Jun Soo Lee, Ami Bhatt, Sandra L Jackson, Lisa M Pollack, Nina Omeaku, Kincaid Lowe, et al. (+3) Cidney Wilson, Feijun Luo, Kakoli Roy |
| 3 |
[GO] |
2023―Mai―30 |
Clinical Practice Changes in Monitoring Hypertension Early in the COVID-19 Pandemic by Robbins et al. Am J Hypertens (2022) 35 (7): 596-600. https://doi.org/10.1093/ajh/hpac049 |
|
| 4 |
[GO] |
2023―Apr―22 |
Trends and Characteristics of Blood Pressure Prescription Fills Before and During the COVID-19 Pandemic in the United States |
Peter K Yang, So Youn Park, Sandra L Jackson, Sharon Attipoe-Dorcoo, Elizabeth Gray, Matthew D Ritchey, Laurence S Sperling |
| 5 |
[GO] |
2023―Apr―03 |
Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic |
Lweendo Muchaili, Bislom C Mweene, Sepiso K Masenga |
| 6 |
[GO] |
2023―Mrz―24 |
Discontinuation of Renin-Angiotensin System Inhibitors During the Early Stage of the COVID-19 Pandemic |
Paul Muntner, Kathryn Foti, Zhixin Wang, Chibuike J Alanaeme, Eunhee Choi, Adam P Bress, et al. (+2) Daichi Shimbo, Ian Kronish |
| 7 |
[GO] |
2022―Aug―24 |
24-Hour Central Hemodynamic Load in Adults With and Without a History of COVID-19 |
Andrew R Heckel, Danielle M Arcidiacono, Kailee A Coonan, Alaina C Glasgow, Jacob P DeBlois, Brooks B Gump, et al. (+2) Joon Young Kim, Kevin S Heffernan |
| 8 |
[GO] |
2022―Jun―03 |
An updated systematic review and meta-analysis of randomized trials on the effects of angiotensin II receptor blockers on the risk of mortality in patients with COVID-19 |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 9 |
[GO] |
2022―Apr―11 |
Clinical Practice Changes in Monitoring Hypertension early in the COVID-19 Pandemic |
Cheryl L Robbins, Nicole D Ford, Donald K Hayes, Jean Y Ko, Elena Kuklina, Shanna Cox, et al. (+2) Cynthia Ferre, Fleetwood Loustalot |
| 10 |
[GO] |
2021―Aug―16 |
Updates on renin-angiotensin system blockers in hypertensive patients with COVID-19 |
Shigeru Shibata, Takuya Kishi |
| 11 |
[GO] |
2021―Jul―14 |
Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial |
Farhad Najmeddin, Maedeh Solhjoo, Haleh Ashraf, Mohammadreza Salehi, Fatemeh Rasooli, Morteza Ghoghaei, et al. (+2) Abbas Soleimani, Maryam Bahreini |
| 12 |
[GO] |
2021―Jun―22 |
The Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker on the Outcome of Hospitalization of Patients With Hypertension and COVID-19 |
Xi-jing Zhuang, Wen-jun Wang, Xiao-hui Zhao, Wei Wei, Wei-wang Fan, Kai Gao, et al. (+2) Sheng-xiu He, Hai-long Lin |
| 13 |
[GO] |
2021―Jun―12 |
Possible Pleiotropic Effect Of Sry Gene May Increase Male Susceptibility To Covid-19 |
Victor G O Evangelho, Murilo L Bello, Helena C Castro, Marcia R Amorim |
| 14 |
[GO] |
2020―Dez―31 |
SARS-COV-2 RECEPTOR ACE2 GENE is associated with hypertension and SEVERity of COVID 19: interaction with sex, obesity and SMOKING |
Pavel Hamet, Zdenka Pausova, Redha Attaoua, Camil Hishmih, Mounsif Haloui, Jean Shin, et al. (+8) Tomas Paus, Michal Abrhamowicz, Daniel Gaudet, Lara Santucci, Theodore A Kotchen, Allen W Cowley, Julie Hussin, Johanne Tremblay |
| 15 |
[GO] |
2020―Nov―03 |
Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and COVID-19: Demonstrating the Actionability of Real World Evidence |
Sean Hennessy, Jordana B Cohen |
| 16 |
[GO] |
2020―Nov―03 |
How important is the assessment of soluble ACE-2 in COVID-19? |
Manuel Rojas, Yeny Acosta-Ampudia, Diana M. Monsalve, Carolina Ramírez-Santana, Juan-Manuel Anaya |
| 17 |
[GO] |
2020―Sep―11 |
Effects of angiotensin receptor blockers (ARBs) on in-hospital outcomes of patients with hypertension and confirmed or clinically suspected COVID-19 |
Abbas Soleimani, Sina Kazemian, Shahrokh Karbalai Saleh, Arya Aminorroaya, Zahra Shajari, Azar Hadadi, et al. (+9) Mohammad Talebpour, Hakimeh Sadeghian, Pooya Payandemehr, Mehran Sotoodehnia, Maryam Bahreini, Farhad Najmeddin, Ali Heidarzadeh, Ensieh Zivari, Haleh Ashraf |
| 18 |
[GO] |
2020―Jun―05 |
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives |
C Felice, C Nardin, G L Di Tanna, U Grossi, E Bernardi, L Scaldaferri, et al. (+12) M Romagnoli, L Tonon, P Cavasin, S Novello, R Scarpa, A Farnia, E De Menis, R Rigoli, F Cinetto, P Pauletto, C Agostini, M Rattazzi |
| 19 |
[GO] |
2020―Mai―21 |
Cost-Related Antihypertensive Medication Nonadherence:Action in the Time of COVID-19 and Beyond |
Gabriel S Tajeu, Paul Muntner |
|
